In CTCL, cMyc accumulation was associated with poor clinical outcome of the advanced stages of mycosis fungoides and Sèzary syndrome [15], [16]. The gene discussed is MYC; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.